Myocardial infarction in sickle cell disease: Use of translational imaging to diagnose an under-recognized problem

Journal of Cardiovascular Translational Research

Volumn 6, Issue 5, 2013, Pages 752-761

  Chacko, Paul ^a   Kraut, Eric H ^a   Zweier, Jay ^a   Hitchcock, Charles ^a   Raman, Subha V ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Ischemic heart disease; Magnetic resonance; Microcirculation; Myocardial infarction; Sickle cell disease

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BIOAVAILABILITY; BLOOD CLOTTING; BLOOD VESSEL OCCLUSION; BLOOD VESSEL TONE; CARDIOVASCULAR MAGNETIC RESONANCE; CELL ADHESION; CODON; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; IONIZING RADIATION; MICROCIRCULATION; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SICKLE CELL ANEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANEMIA, SICKLE CELL; CORONARY CIRCULATION; CORONARY STENOSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MICROCIRCULATION; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84885603263     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9426-z     Document Type: Article

References (75)

1. Weatherall, D. J. (2010). The inherited diseases of hemoglobin are an emerging global health burden. Blood, 115, 4331-4336.
2. NHS Sickle Cell & Thalassaemia Screening Programme. http://sct.screening.nhs.uk/. Accessed 27 April 2012.
3. CDC. http://www.cdc.gov/Features/SickleCellAwareness/. Accessed 13 August 2011.
4. Pavlu, J., Ahmed, R. E., O'Regan, D. P., Partridge, J., Lefroy, D. C., & Layton, D. M. (2007). Myocardial infarction in sickle-cell disease. Lancet, 369, 246.
5. Powars, D. R., Chan, L. S., Hiti, A., Ramicone, E., & Johnson, C. (2005). Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore), 84, 363-376.
6. Mekontso Dessap, A., Leon, R., Habibi, A., Nzouakou, R., Roudot-Thoraval, F., Adnot, S., Godeau, B., Galacteros, F., Brun-Buisson, C., Brochard, L., & Maitre, B. (2008). Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. American Journal of Respiratory and Critical Care Medicine, 177, 646-653.
7. Castro, O., & Gladwin, M. T. (2005). Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management. Hematology/Oncology Clinics of North America, 19, 881-896.
8. Powars, D., Weidman, J. A., Odom-Maryon, T., Niland, J. C., & Johnson, C. (1988). Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore), 67, 66-76.
9. Herrick, J. B. (1910). Peculiar elongated and sickled red blood corpuscles in a case of severe anaemia. Archives of Internal Medicine, 6, 517-521.
10. James, T. N. (2000). Homage to James B. Herrick: a contemporary look at myocardial infarction and at sickle-cell heart disease: the 32nd Annual Herrick Lecture of the Council on Clinical Cardiology of the American Heart Association. Circulation, 101, 1874-1887.
11. Fertrin, K. Y., & Costa, F. F. (2010). Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment. Expert Review of Hematology, 3, 443-458.
12. Stuart, M. J., & Nagel, R. L. (2004). Sickle-cell disease. Lancet, 364, 1343-1360.
13. Orkin, S. H., & Higgs, D. R. (2010). Medicine. Sickle cell disease at 100 years. Science, 329, 291-292.
14. Lanzkron, S., Strouse, J. J., Wilson, R., Beach, M. C., Haywood, C., Park, H., Witkop, C., Bass, E. B., & Segal, J. B. (2008). Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease. Annals of Internal Medicine, 148, 939-955.
15. Morris, C. R. (2008). Mechanisms of vasculopathy in sickle cell disease and thalassemia. Hematology American Society of Hematology Education Program, 2008, 177-185.
16. Wood, K. C., Hsu, L. L., & Gladwin, M. T. (2008). Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radical Biology & Medicine, 44, 1506-1528.
17. Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., 3rd, Schechter, A. N., & Gladwin, M. T. (2002). Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 1383-1389.
18. Aslan, M., & Freeman, B. A. (2004). Oxidant-mediated impairment of nitric oxide signaling in sickle cell disease - mechanisms and consequences. Cellular and Molecular Biology (Noisy-le-Grand, France), 50, 95-105.
19. Machado, R. F., Martyr, S., Kato, G. J., Barst, R. J., Anthi, A., Robinson, M. R., Hunter, L., Coles, W., Nichols, J., Hunter, C., Sachdev, V., Castro, O., & Gladwin, M. T. (2005). Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension. British Journal of Haematology, 130, 445-453.
20. Assanasen, C., Quinton, R. A., & Buchanan, G. R. (2003). Acute myocardial infarction in sickle cell anemia. Journal of Pediatric Hematology/Oncology, 25, 978-981.
21. Barrett, O., Jr., Saunders, D. E., Jr., McFarland, D. E., & Humphries, J. O. (1984). Myocardial infarction in sickle cell anemia. American Journal of Hematology, 16, 139-147.
22. Dang, N. C., Johnson, C., Eslami-Farsani, M., & Haywood, L. J. (2005). Myocardial injury or infarction associated with fat embolism in sickle cell disease: a report of three cases with survival. American Journal of Hematology, 80, 133-136.
23. de Montalembert, M., Maunoury, C., Acar, P., Brousse, V., Sidi, D., & Lenoir, G. (2004). Myocardial ischaemia in children with sickle cell disease. Archives of Disease in Childhood, 89, 359-362.
24. Deymann, A. J., & Goertz, K. K. (2003). Myocardial infarction and transient ventricular dysfunction in an adolescent with sickle cell disease. Pediatrics, 111, E183-187.
25. Martin, C. R., Cobb, C., Tatter, D., Johnson, C., & Haywood, L. J. (1983). Acute myocardial infarction in sickle cell anemia. Archives of Internal Medicine, 143, 830-831.
26. Martin, C. R., Johnson, C. S., Cobb, C., Tatter, D., & Haywood, L. J. (1996). Myocardial infarction in sickle cell disease. Journal of the National Medical Association, 88, 428-432.
27. Maunoury, C., Acar, P., de Montalembert, M., & Sidi, D. (2003). Myocardial perfusion in children with sickle cell disease. The American Journal of Cardiology, 91, 374-376.
28. McCormick, W. F. (1988). Massive nonatherosclerotic myocardial infarction in sickle cell anemia. The American Journal of Forensic Medicine and Pathology, 9, 151-154.
29. Norris, S., Johnson, C. S., & Haywood, L. J. (1991). Sickle cell anemia: does myocardial ischemia occur during crisis? Journal of the National Medical Association, 83, 209-213.
30. Saad, S. T., Arruda, V. R., Junqueira, O. O., Schelini, F. A., & Coelho, O. B. (1990). Acute myocardial infarction in sickle cell anaemia associated with severe hypoxia. Postgraduate Medical Journal, 66, 1068-1070.
31. Sherman, S. C., & Sule, H. P. (2004). Acute myocardial infarction in a young man with sickle cell disease. The Journal of Emergency Medicine, 27, 31-35.
32. Wang, H., Laslett, L. J., Richman, C. M., & Wun, T. (2004). Acute myocardial infarction in hemoglobin SC disease. Annals of Hematology, 83, 622-624.
33. Oliveira, E. N. G.-P. (1963). Falcemic cardiopathy: report of a case. The American Journal of Cardiology, 11, 686-688.
34. Manci, E. A., Culberson, D. E., Yang, Y. M., Gardner, T. M., Powell, R., Haynes, J., Jr., Shah, A. K., & Mankad, V. N. (2003). Causes of death in sickle cell disease: an autopsy study. British Journal of Haematology, 123, 359-365.
35. Fitzhugh, C. D., Lauder, N., Jonassaint, J. C., Telen, M. J., Zhao, X., Wright, E. C., Gilliam, F. R., & De Castro, L. M. (2010). Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. American Journal of Hematology, 85, 36-40.
36. Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994). Mortality in sickle cell disease. Life expectancy and risk factors for early death. New England Journal of Medicine, 330, 1639-1644.
37. Kannel, W. B., Gordon, T., Castelli, W. P., & Margolis, J. R. (1970). Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Annals of Internal Medicine, 72, 813-822.
38. Covitz, W., Espeland, M., Gallagher, D., Hellenbrand, W., Leff, S., & Talner, N. (1995). The heart in sickle cell anemia. The Cooperative Study of Sickle Cell Disease (CSSCD). Chest, 108, 1214-1219.
39. Lester, L. A., Sodt, P. C., Hutcheon, N., & Arcilla, R. A. (1990). Cardiac abnormalities in children with sickle cell anemia. Chest, 98, 1169-1174.
40. Francis, R. B., Jr., & Johnson, C. S. (1991). Vascular occlusion in sickle cell disease: current concepts and unanswered questions. Blood, 77, 1405-1414.
41. Maisel, A., Friedman, H., Flint, L., Koshy, M., & Prabhu, R. (1983). Continuous electrocardiographic monitoring in patients with sickle-cell anemia during pain crisis. Clinical Cardiology, 6, 339-344.
42. Pannu, R., Zhang, J., Andraws, R., Armani, A., Patel, P., & Mancusi-Ungaro, P. (2008). Acute myocardial infarction in sickle cell disease: a systematic review. Critical Pathways in Cardiology, 7, 133-138.
43. Mansi, I. A., & Rosner, F. (2002). Myocardial infarction in sickle cell disease. Journal of the National Medical Association, 94, 448-452.
44. Thygesen, K., Alpert, J. S., & White, H. D. (2007). Universal definition of myocardial infarction. Journal of the American College of Cardiology, 50, 2173-2195.
45. Aslam, A. K., Rodriguez, C., Aslam, A. F., Vasavada, B. C., & Khan, I. A. (2009). Cardiac troponin I in sickle cell crisis. International Journal of Cardiology, 133, 138-139.
46. Lippi, G., De Franceschi, L., Salvagno, G. L., Pavan, C., Montagnana, M., & Guidi, G. C. (2009). Cardiac troponin T during sickle cell crisis. International Journal of Cardiology, 136, 357-358.
47. Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., Hunter, L. A., Blackwelder, W. C., Schechter, A. N., Rodgers, G. P., Castro, O., & Ognibene, F. P. (2004). Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. The New England Journal of Medicine, 350, 886-895.
48. Simmons, B. E., Santhanam, V., Castaner, A., Rao, K. R., Sachdev, N., & Cooper, R. (1988). Sickle cell heart disease. Two-dimensional echo and Doppler ultrasonographic findings in the hearts of adult patients with sickle cell anemia. Archives of Internal Medicine, 148, 1526-1528.
49. Parent, F., Bachir, D., Inamo, J., Lionnet, F., Driss, F., Loko, G., Habibi, A., Bennani, S., Savale, L., Adnot, S., Maitre, B., Yaici, A., Hajji, L., O'Callaghan, D. S., Clerson, P., Girot, R., Galacteros, F., & Simonneau, G. (2011). A hemodynamic study of pulmonary hypertension in sickle cell disease. The New England Journal of Medicine, 365, 44-53.
50. Sachdev, V., Machado, R. F., Shizukuda, Y., Rao, Y. N., Sidenko, S., Ernst, I., St Peter, M., Coles, W. A., Rosing, D. R., Blackwelder, W. C., Castro, O., Kato, G. J., & Gladwin, M. T. (2007). Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. Journal of the American College of Cardiology, 49, 472-479.
51. Peltier, M., Vancraeynest, D., Pasquet, A., Ay, T., Roelants, V., D'Hondt, A. M., Melin, J. A., & Vanoverschelde, J. L. (2004). Assessment of the physiologic significance of coronary disease with dipyridamole real-time myocardial contrast echocardiography. Comparison with technetium-99m sestamibi single-photon emission computed tomography and quantitative coronary angiography. Journal of the American College of Cardiology, 43, 257-264.
52. Almeida, A. G., Araujo, F., Rego, F., David, C., Lopes, M. G., & Ducla-Soares, J. (2008). Abnormal myocardial flow reserve in sickle cell disease: a myocardial contrast echocardiography study. Echocardiography, 25, 591-599.
53. Honos, G., Amyot, R., Choy, J., Leong-Poi, H., Schnell, G., & Yu, E. (2007). Contrast echocardiography in Canada: Canadian Cardiovascular Society/Canadian Society of Echocardiography position paper. Canadian Journal of Cardiology, 23, 351-356.
54. Gerber, B. L., Raman, S. V., Nayak, K., Epstein, F. H., Ferreira, P., Axel, L., & Kraitchman, D. L. (2008). Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. Journal of Cardiovascular Magnetic Resonance, 10, 18.
55. Panting, J. R., Gatehouse, P. D., Yang, G. Z., Grothues, F., Firmin, D. N., Collins, P., & Pennell, D. J. (2002). Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. The New England Journal of Medicine, 346, 1948-1953.
56. Raman, S. V., Simonetti, O. P., Cataland, S. R., & Kraut, E. H. (2006). Myocardial ischemia and right ventricular dysfunction in adult patients with sickle cell disease. Haematologica, 91, 1329-1335.
57. Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, Sheppard MN, Porter JB, Walker JM, Wood JC, Galanello R, Forni G, Catani G, Matta G, Fucharoen S, Fleming A, House MJ, Black G, Firmin DN, St Pierre TG, Pennell DJ (2011) On T2*magnetic resonance and cardiac iron. Circulation 123:1519-1528
58. Wood, J. C., Tyszka, J. M., Carson, S., Nelson, M. D., & Coates, T. D. (2004). Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood, 103, 1934-1936.
59. Kim, R. J., Fieno, D. S., Parrish, T. B., Harris, K., Chen, E. L., Simonetti, O., Bundy, J., Finn, J. P., Klocke, F. J., & Judd, R. M. (1999). Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation, 100, 1992-2002.
60. Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Jr., Chavey, W. E., 2nd, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C., Jr., Jacobs, A. K., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., & Riegel, B. (2007). ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Journal of the American College of Cardiology, 50, e1-e157.
61. Antman, E. M., Hand, M., Armstrong, P. W., Bates, E. R., Green, L. A., Halasyamani, L. K., Hochman, J. S., Krumholz, H. M., Lamas, G. A., Mullany, C. J., Pearle, D. L., Sloan, M. A., Smith, S. C., Jr., Anbe, D. T., Kushner, F. G., Ornato, J. P., Jacobs, A. K., Adams, C. D., Anderson, J. L., Buller, C. E., Creager, M. A., Ettinger, S. M., Halperin, J. L., Hunt, S. A., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B., Tarkington, L. G., & Yancy, C. W. (2008). 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation, 117, 296-329.
62. Russell, M. O., Goldberg, H. I., Hodson, A., Kim, H. C., Halus, J., Reivich, M., & Schwartz, E. (1984). Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood, 63, 162-169.
63. Khalique Z, Pavlu J, Lefroy D, Layton M (2010) Erythrocytapheresis in the prevention of recurrent myocardial infarction in sickle cell disease. American Journal of Hematology 85:91
64. Atz, A. M., & Wessel, D. L. (1997). Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology, 87, 988-990.
65. Sullivan, K. J., Goodwin, S. R., Evangelist, J., Moore, R. D., & Mehta, P. (1999). Nitric oxide successfully used to treat acute chest syndrome of sickle cell disease in a young adolescent. Critical Care Medicine, 27, 2563-2568.
66. Head CA, Swerdlow P, McDade WA, Joshi RM, Ikuta T, Cooper ML, Eckman JR (2010) Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis. American Journal of Hematology 85:800-802
67. Gladwin MT, Kato GJ, Weiner D, Onyekwere OC, Dampier C, Hsu L, Hagar RW, Howard T, Nuss R, Okam MM, Tremonti CK, Berman B, Villella A, Krishnamurti L, Lanzkron S, Castro O, Gordeuk VR, Coles WA, Peters-Lawrence M, Nichols J, Hall MK, Hildesheim M, Blackwelder WC, Baldassarre J, Casella JF (2011) Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA 305:893-902
68. Hataishi, R., Rodrigues, A. C., Neilan, T. G., Morgan, J. G., Buys, E., Shiva, S., Tambouret, R., Jassal, D. S., Raher, M. J., Furutani, E., Ichinose, F., Gladwin, M. T., Rosenzweig, A., Zapol, W. M., Picard, M. H., Bloch, K. D., & Scherrer-Crosbie, M. (2006). Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. American Journal of Physiology. Heart and Circulatory Physiology, 291, H379-H384.
69. Theuns, D. A., Smith, T., Hunink, M. G., Bardy, G. H., & Jordaens, L. (2010). Effectiveness of prophylactic implantation of cardioverter- defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. Europace, 12, 1564-1570.
70. Fibach, E. (2001). Cell culture and animal models to screen for promising fetal hemoglobin-stimulating compounds. Seminars in Hematology, 38, 374-381.
71. Hebbel, R. P., Vercellotti, G. M., Pace, B. S., Solovey, A. N., Kollander, R., Abanonu, C. F., Nguyen, J., Vineyard, J. V., Belcher, J. D., Abdulla, F., Osifuye, S., Eaton, J. W., Kelm, R. J., Jr., & Slungaard, A. (2010). The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice. Blood, 115, 2483-2490.
72. Woodruff, A. W. (1970). Sickle-cell anaemia with complicating coronary infarction. Proceedings of the Royal Society of Medicine, 63, 1314.
73. Rubler, S., & Fleischer, R. A. (1967). Sickle cell states and cardiomyopathy. Sudden death due to pulmonary thrombosis and infarction. The American Journal of Cardiology, 19, 867-873.
74. Uzsoy, N. K. (1964). Cardiovascular findings in patients with sickle cell anemia. The American Journal of Cardiology, 13, 320-328.
75. Tanner, M. A., Westwood, M. A., & Pennell, D. J. (2006). Myocardial infarction following sickle cell chest syndrome. British Journal of Haematology, 134, 2.